UY34745A - VACCINES AND PROCEDURES TO TREAT LYME'S DISEASE IN DOGS - Google Patents
VACCINES AND PROCEDURES TO TREAT LYME'S DISEASE IN DOGSInfo
- Publication number
- UY34745A UY34745A UY0001034745A UY34745A UY34745A UY 34745 A UY34745 A UY 34745A UY 0001034745 A UY0001034745 A UY 0001034745A UY 34745 A UY34745 A UY 34745A UY 34745 A UY34745 A UY 34745A
- Authority
- UY
- Uruguay
- Prior art keywords
- vaccines
- dogs
- disease
- procedures
- immunogenic composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención proporciona una composición inmunógena que comprende un fragmento antigénico de proteína OspA de Borrelia burgdorferi y una proteína quimérica que contiene fragmentos antigénicos de diferentes filotipos de proteína OspC de Borrelia burgdorferi. También se proporcionan vacunas que incorporan la composición inmunógena de la invención, así como procedimientos para prevenir la e nfermedad de Lyme en perros y/o proteger perros de la enfermedad de Lyme usando las vacunas.The present invention provides an immunogenic composition comprising an antigenic fragment of Borrelia burgdorferi OspA protein and a chimeric protein containing antigenic fragments of different Borprelia burgdorferi OspC protein filotypes. Vaccines that incorporate the immunogenic composition of the invention, as well as methods for preventing Lyme disease in dogs and / or protecting dogs from Lyme disease using vaccines are also provided.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261635031P | 2012-04-18 | 2012-04-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY34745A true UY34745A (en) | 2013-11-29 |
Family
ID=48193279
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001034745A UY34745A (en) | 2012-04-18 | 2013-04-16 | VACCINES AND PROCEDURES TO TREAT LYME'S DISEASE IN DOGS |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP2838555A2 (en) |
JP (1) | JP2015514776A (en) |
CN (1) | CN104379164A (en) |
AR (1) | AR090726A1 (en) |
AU (1) | AU2013249229A1 (en) |
BR (1) | BR112014025740A2 (en) |
CA (1) | CA2870179C (en) |
EA (1) | EA201491668A1 (en) |
UY (1) | UY34745A (en) |
WO (1) | WO2013158818A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3204404A4 (en) | 2014-10-08 | 2018-06-06 | Virginia Commonwealth University | Stage specific diagnostic antigens, assay and vaccine for lyme disease |
US11883476B2 (en) | 2017-12-04 | 2024-01-30 | Intervet Inc. | Canine lyme disease vaccine |
CN110483624B (en) * | 2019-08-22 | 2021-02-09 | 中国疾病预防控制中心传染病预防控制所 | Borrelia garinii OspA protein C-terminal peptide segment and application thereof |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4567042A (en) | 1983-06-15 | 1986-01-28 | American Home Products Corporation | Inactivated canine coronavirus vaccine |
US4567043A (en) | 1983-06-15 | 1986-01-28 | American Home Products Corporation (Del.) | Canine corona virus vaccine |
US6872550B1 (en) | 1991-07-11 | 2005-03-29 | Baxter Vaccine Ag | Immunogenic formulation of OspC antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens |
ATE181572T1 (en) * | 1991-08-15 | 1999-07-15 | Smithkline Beecham Biolog | OSPA PROTEINS OF BORRELIA BURGDORFERI SUBGROUPS, GENES CODING FOR THEM AND VACCINES |
PT1100922E (en) | 1998-07-31 | 2008-05-30 | Gundersen Lutheran Medical Fou | Uses of the borreliacidal epitope(s) of borrelia burgdorferi outer surface protein c (ospc) as vaccine |
WO2009135118A2 (en) * | 2008-05-02 | 2009-11-05 | Virginia Commonwealth University | Lyme disease vaccine |
WO2010132758A2 (en) * | 2009-05-14 | 2010-11-18 | Gomes-Solecki Maria J | Ospc-based diagnostic test for lyme disease |
US8808705B2 (en) * | 2010-10-20 | 2014-08-19 | Virginia Commonwealth University | Polyvalent chimeric OspC vaccinogen and diagnostic antigen |
-
2013
- 2013-04-16 UY UY0001034745A patent/UY34745A/en not_active Application Discontinuation
- 2013-04-17 AR ARP130101267A patent/AR090726A1/en unknown
- 2013-04-18 BR BR112014025740A patent/BR112014025740A2/en not_active IP Right Cessation
- 2013-04-18 WO PCT/US2013/037063 patent/WO2013158818A2/en active Application Filing
- 2013-04-18 JP JP2015507162A patent/JP2015514776A/en active Pending
- 2013-04-18 EP EP13719257.1A patent/EP2838555A2/en not_active Withdrawn
- 2013-04-18 CA CA2870179A patent/CA2870179C/en active Active
- 2013-04-18 AU AU2013249229A patent/AU2013249229A1/en not_active Abandoned
- 2013-04-18 EA EA201491668A patent/EA201491668A1/en unknown
- 2013-04-18 CN CN201380030342.1A patent/CN104379164A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP2838555A2 (en) | 2015-02-25 |
EA201491668A1 (en) | 2015-08-31 |
JP2015514776A (en) | 2015-05-21 |
AR090726A1 (en) | 2014-12-03 |
CN104379164A (en) | 2015-02-25 |
BR112014025740A2 (en) | 2017-07-04 |
WO2013158818A2 (en) | 2013-10-24 |
AU2013249229A1 (en) | 2014-10-23 |
CA2870179A1 (en) | 2013-10-24 |
WO2013158818A3 (en) | 2014-04-17 |
CA2870179C (en) | 2018-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL267997A (en) | Compositions, formulations and methods for treating ocular diseases | |
CO7160093A2 (en) | Anti-egfr antibodies and uses thereof | |
BR112012005225B8 (en) | USE OF AN ACTRIIB-FC FUSION PROTEIN FOR THE TREATMENT OF A DISORDER RELATED TO BONE OR ASSOCIATED WITH MUSCLE LOSS DUE TO FAULT MUSCLE GROWTH | |
MX2015011199A (en) | Csf1 therapeutics. | |
AR090465A1 (en) | SOLID FORMS OF A THIOPHOSPHORAMIDATE NUCLEOTIDE PROFARMACO | |
CL2014002549A1 (en) | Anti-lgr5 and immunoconjugate antibodies; pharmaceutical formulation that contains them; treatment method in which anti-lgr5 and immunoconjugate antibodies are administered. | |
MX2012013261A (en) | Chimeric ospa genes, proteins, and methods of use thereof. | |
DOP2013000235A (en) | FUSION PROTEINS AND COMBINATION VACCINES THAT INCLUDE PROTEIN E AND PILINA A OF HAEMOPHILUS INFLUENZAE. | |
IN2014DN08676A (en) | ||
MX2021004211A (en) | Vaccine compositions. | |
CL2015003343A1 (en) | Pharmaceutical composition comprising a modified therapeutic agent based on hemoglobin, for the treatment to treat cancer, and diagnostic images. | |
NZ703597A (en) | Mutant fragments of ospa and methods and uses relating thereto | |
ECSP13012893A (en) | ASYMMETRIC UREAS AND MEDICAL USES OF THE SAME | |
UA114286C2 (en) | Methods and compositions for vaccinating against staphylococcus aureus | |
BR112015020079A8 (en) | COMPOSITIONS FOR ORAL CARE | |
CL2015003563A1 (en) | Marker for acid sphingomyelinase disorders and their uses. | |
BR112015001843A2 (en) | medical device, biodegradable matrix composition and method for treating a patient. | |
UY34745A (en) | VACCINES AND PROCEDURES TO TREAT LYME'S DISEASE IN DOGS | |
WO2014018274A8 (en) | Compositions comprising chimeric ospa molecules and methods of use thereof | |
EP2926822A4 (en) | Pharmaceutical composition containing sceptridium japonicum extract for preventing or treating stroke or degenerative brain diseases | |
BR112017004304A2 (en) | topical pteroestilbene compositions for use in treating UV-induced skin barrier function loss | |
GT201500230A (en) | HERBICIDE COMPOSITION | |
BR112015010675A2 (en) | block copolymers for tooth enamel protection | |
MX2015011053A (en) | Oral care compositions. | |
CY1118255T1 (en) | Substituted 6-amino-nicotinamides which carry a group containing KCNQ2 / 3 modulators |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20210526 |